Search the hub
Showing results for tags 'Asthma'.
-
News ArticleHarry Miller was a popular teenager, appreciated for his sharp humour, ability to get on with anyone and eagerness “for the next adventure”. In the autumn of 2017, he was struggling with difficult thoughts and feelings of anger. Harry, who was 14 and lived in south-west London, confided his inner turmoil to friends and family. “I’m just having these anger rages,” he told his mother one day. “It’s like I just go crazy suddenly and I can’t control it. I don’t know what’s going on.” Two years previously, Harry had been prescribed the drug montelukast for his asthma. Unbeknown to his parents, a range of psychiatric reactions had been reported in association with montelukast treatment, including aggression, depression and suicidal thoughts. Harry’s parents, Graham and Alison Miller were not properly warned of the potential side effects. Their son was referred to the NHS child and adolescent mental health services in January 2018, but he missed an appointment because it was sent to the wrong person. On 11 February 2018, Harry was found dead in the family home, with an inquest later recording a verdict of suicide. He was described in a tribute by friends at St Cecilia’s Church of England school in Southfields, south-west London, as a “super star burning brightly”. Two years after his death, his father read an online warning about the adverse reactions involving montelukast by the Medicines and Healthcare Products Regulatory Agency (MHRA). It said these could very rarely include suicidal behaviour. Graham Miller said: “It is an absolute outrage that parents are being given psychoactive substances to give to their children without proper warning of the risk.” This weekend, the MHRA has confirmed that the drug is under review. A montelukast UK action group is calling for more prominent warnings of the drug’s possible side effects. Read full story Source: BBC News, 3 March 2024
- Posted
-
- Asthma
- Medication
- (and 4 more)
-
Content ArticleSalbutamol is a selective beta2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. The nebuliser liquids are licensed for use in the management of chronic bronchospasm unresponsive to conventional therapy, and in the treatment of acute severe asthma. A Medicines Supply Notification (MSN) issued on 14 February 2024, detailed a shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid. The resolution date is to be confirmed. The supply issues have been caused by a combination of manufacturing issues resulting in increased demand on other suppliers. Terbutaline, salbutamol with ipratropium, and ipratropium nebuliser liquids remain available, however, they cannot support an increase in demand. Ventolin® (salbutamol) 5mg/ml nebuliser liquid (20ml) is out of stock until mid-April 2024 and cannot support an increased demand after this date.
- Posted
-
- Medication
- Lack of resources
-
(and 2 more)
Tagged with:
-
Content ArticleThis study in the British Journal of General Practice aimed to assess the risk of poor respiratory outcomes for people with resolved asthma compared to those with active asthma and people without asthma. The authors used three retrospective cohorts of around 16,000 patients each, in the following groups: Active asthma cohort (patients with an asthma-specific diagnostic code at any point in their GP record, and >1 asthma medication prescription). Resolved asthma cohort (patients with >1 resolved asthma code, followed from date of first resolved asthma during the study period to the earliest data of an asthma prescription, the end of the study period, date of transfer out of practice or death). Non-asthma cohort (population-based patients without active or resolved asthma or chronic obstructive pulmonary disease). The results showed that compared to the active asthma cohort, the resolved asthma cohort had fewer GP consultations for asthma exacerbations and fewer asthma hospital admissions. However, compared with non-asthma patients, resolved asthma patients had more GP consultations, greater rates of respiratory tract infections and higher rates of antibiotic use. The authors highlighted a lack of guidance around care pathways for patients with a record of resolved asthma. They concluded that patients with resolved asthma may need a more comprehensive respiratory assessment if they present with symptoms of lower respiratory tract infection, in order to assess symptom burden, airway obstruction and the potential value of inhaled treatment.
-
News Article
Boy, 10, with asthma died due to ‘neglect by healthcare professionals’
Patient-Safety-Learning posted a news article in News
A 10-year-old boy with severe asthma died as a result of multiple failings by healthcare professionals amounting to neglect, a coroner has concluded. William Gray, from Southend, died on 29 May 2021 from a cardiac arrest caused by respiratory arrest, resulting from acute and severe asthma that was “chronically very under controlled”. His death has led to calls to improve asthma treatment for children nationwide. The court heard that William’s death was a “tragedy foretold” having previously suffered a nearly fatal asthma attack on 27 October, 2020, which he survived. The coroner said that William’s death was avoidable, his symptoms were treatable, and he should not have needed to use 16 reliever inhalers over 17 months, but instead his condition should have been treated with preventer medications and should have been controlled. Julie Struthers, a solicitor at Leigh Day who represented the family, said, “In an inquest involving concerns with medical treatment it is rare for a coroner to find neglect, and even rarer for a coroner to find Article 2, a person’s right to life, to be engaged. This reflects the real tragedy of what happened to William, the substantial number of failures by multiple healthcare professionals in his care, and the importance of improving asthma treatment for children nationwide.” Read full story (paywalled) Source: inews, 22 November 2023- Posted
-
- Asthma
- Patient death
-
(and 1 more)
Tagged with:
-
Content ArticleThis report from Asthma + Lung UK highlights that lung diseases such as COPD, asthma and pneumonia are the third leading cause of death in England, whilst the UK as a whole has the worst death rate from lung disease in Europe. Hospital admissions for lung diseases have doubled in the last 20 years and lack of proper testing for lung diseases is having an impact on patient safety, as GPs have to "guess" diagnoses. The report highlights three areas where policy changes should be implemented in order to improve care for people affected, reduce pressure on services and deliver massive savings for the NHS: Diagnosing lung disease early and accurately Keeping people healthy and out of hospital Providing treatments that work
- Posted
-
- Medicine - Respiratory
- Research
- (and 5 more)
-
Content ArticleThis report from the National Asthma and Chronic Obstructive Pulmonary Disease Audit Programme (NACAP) shows what happened after people were admitted to hospital with an asthma attack or COPD exacerbation between 2018 and 2020. The data show that many people are being readmitted to hospital within three months of going home and that some, particularly with COPD, are dying within three months of their exacerbation.
- Posted
-
- Chronic obstructive pulmonary disease
- Asthma
- (and 4 more)
-
Content ArticlePatient engagement is a key component of quality improvement in health. Patient activation is defined as the patient's willingness to manage their health based on understanding their role in the care process and having the knowledge and skills to do so. For children parents have this role. The Parent Patient Activation Measure (Parent-PAM) is adapted from Patient Activation Measure(PAM), a 13-point questionnaire designed to measure healthcare activation. PAM scores are stratified into "levels of activation": Level 1-does not believe the caregiver role is important (score ≤47.0) through to Level 4-takes action, may have difficulty maintaining behaviours (score ≥71). This study, published in the European Respiratory Journal, aimed to evaluate caregiver activation using Parent-PAM in a paediatric difficult asthma(DA)clinic.
- Posted
-
- Patient engagement
- Asthma
-
(and 2 more)
Tagged with:
-
Content ArticleThis report from the National Asthma and COPD Audit Programme (NACAP) offers a view of the care of people with asthma and COPD in England and Wales, and is informed by 103,194 case records submitted to the audit programme. It is the first report to combine data on asthma, COPD and pulmonary rehabilitation across primary and secondary care services to underpin key messages, optimising respiratory care across the pathway.
- Posted
-
- Chronic obstructive pulmonary disease
- Asthma
- (and 5 more)
-
Content ArticleIn this episode of the NICE talks podcast, Consultant Respiratory Physician Dr Hitasha Rupani, Medicines Consultant Clinical Adviser at the National Institute for Health and Care Excellence (NICE) Jonathan Underhill and asthma patient Sheba Joseph discuss NICE’s recently published patient decision aid on asthma inhalers and climate change. The tool supports people with asthma to consider whether they might be able to use inhalers which have a smaller carbon footprint as part of their treatment plan. View the NICE patient decision aid on asthma inhalers and climate change
- Posted
-
- Asthma
- Decision making
- (and 4 more)
-
Content ArticleAn estimated 1.3 billion people—16% of the global population—experience a significant disability today. People with disabilities have the right to the highest standard of health, however, this report by the World Health Organization (WHO) demonstrates that while some progress has been made in recent years, many people with disabilities continue to die earlier and have poorer health than others. The report demonstrates how these poor health outcomes are due to unfair conditions faced by people with disabilities in all areas of life, including in the health system itself.
- Posted
-
- Disability
- Health inequalities
- (and 7 more)
-
Content ArticleCore20PLUS5 is NHS England's approach to reducing health inequalities at both national and system level. The approach defines a target population cohort and identifies five focus clinical areas that require accelerated improvement. This infographic outlines the specific Core20PLUS5 approach to reducing health inequalities for children and young people.
- Posted
-
- Health inequalities
- Health Disparities
- (and 8 more)
-
Community Post
Expert patients and repeat medications
Clive Flashman posted a topic in GP and primary care
- GP practice
- GP
-
(and 3 more)
Tagged with:
It's rare that I post personal information of any kind on a website such as this, but this really irked me so felt it was worth sharing. Context: I've been an Asthma sufferer since the age of 3 years old. I know exactly how to manage my condition having had it for over 50 years, and have always used a blue ventolin inhaler as and when necessary (perhaps once every 2-3 months). I have not had any serious issues with my Asthma for at least 20 years, and then only in Hayfever season. Issue: I only renew my inhaler when it expires, every 2 years or so. Therefore it is not listed on my repeat medications list. My most recent one had just run out, so I needed a replacement. Action: I emailed the GP's website as I knew I was meant to, and received an automated email back saying that I would receive a response within 5 working days. So far so good. Response: I received another email response 2 days later (pretty good!) saying that the GP would have to call me to run through why I needed a new inhaler. GP call: The GP rang on the set day and within the allocated time window and started asking me how often I used the inhaler, for what, and did I really need that or the preventative one (which I've had before). At the end of our 10 minute call, she agreed that I just needed a replacement blue ventolin inhaler, as I had asked for in the first place. What a waste of the GP's time, and mine!! It made me think that it would be a helpful thing if certain patients with decades of experience in managing their condition(s) in a very stable way could be classed as 'expert patients' on their GP record. This could save a huge amount of wasted time on both sides!! This blog post first appeared on Linkedin on 30 October 2022. I will post some of the responses to it below for added insight.- Posted
- 14 replies
-
- GP practice
- GP
-
(and 3 more)
Tagged with:
-
Content ArticleM was a young boy who had severe asthma, resulting in regular trips to A&E. His condition was eventually well controlled with a Seretide inhaler. When M's family moved house and changed their GP, they requested a new prescription of Seretide, but when they got to the pharmacy were given the wrong type of inhaler used to treat a different form of asthma. The GP had unwittingly chosen the wrong medication from a drop-down menu. M and his family were unaware that he was taking the wrong medication, and after a few days, M became breathless and his family decided to take him to hospital. Sadly, he died on the journey to A&E. At the inquest, the Coroner found that there two main issues that contributed to M’s death: the unintentional prescription of Serevent the failure to arrange and organise follow up contributed to M’s death.
- Posted
-
- Asthma
- Children and Young People
-
(and 5 more)
Tagged with:
-
News Article
Asthma attacks in more than 1m people linked to UK cost of living rationing
Patient Safety Learning posted a news article in News
More than a million people in the UK have experienced life-threatening asthma attacks after cutting back on medicine, heating or food amid the soaring cost of living crisis, a survey suggests. One in five (20%) people living with asthma in the UK – of which there are 5.4 million – have had an attack as a result of changes they have been forced to make due to rising energy, food and household bills, according to the research by Asthma + Lung UK. Fuel poverty campaigners described the figures as “distressing”. Almost half of the 3,600 people with lung conditions such as asthma, chronic obstructive pulmonary disease (COPD) and bronchiectasis surveyed by the charity said their health had worsened since the crisis began. Asthma + Lung UK warned there could be a “tidal wave” of hospital admissions in the next few months as cold weather, an abundance of viruses and people cutting back on medicines, heating, food and electricity put them at increased risk. Sarah Woolnough, the charity’s chief executive, said: “Untenable cost of living hikes are forcing people with lung conditions to make impossible choices about their health. “Warm homes, regular medicine and a healthy diet are all important pillars to good lung condition management – but they all come at a cost. We are hearing from people already reporting a sharp decline in their lung health, including many having life-threatening asthma attacks. Read full story Source: The Guardian, 28 September 2022- Posted
-
- Asthma
- Chronic obstructive pulmonary disease
- (and 3 more)
-
Content ArticleSpecialist inspectors have identified cases of Salbutamol inhaler overprescribing of up to six inhalers per prescription by online prescribers. This article explores the risks of prescribing high volumes of Salbutamol inhalers. It highlights the need for ongoing patient monitoring, counselling advice, inhaler device choices and discuss the clinical considerations when continuing treatment.
- Posted
-
- Asthma
- Adminstering medication
-
(and 1 more)
Tagged with:
-
Content Article
Survey - Asthma is worse for women (27 April 2022)
Patient-Safety-Learning posted an article in Women's health
Women often have worse asthma than men, and female sex hormones can affect the condition. Asthma and Lung UK are conducting a survey to find out more about women's experience of asthma - women with asthma and those that care for them are invited to take the survey, which takes about five minutes to complete and is completely anonymous. Asthma and Lung UK have also published a report, Asthma is Worse for Women, outlining the need for more research into asthma and female sex hormones.- Posted
-
- Asthma
- Health inequalities
- (and 4 more)
-
Content ArticleGlobally, there are 136 million women with asthma. Asthma is more common among women, women experience more severe symptoms and they are more likely to die from their asthma. Many women experience a significant worsening of symptoms around menstruation and are at risk of potentially fatal asthma attacks every month. However, there has been very little research to understand why. Asthma and Lung UK has published this report following a roundtable meeting with scientists, funders and pharmaceutical companies to discuss how to transform outcomes for women with asthma. The report covers information on sex bias in asthma and looks at recent developments in understanding about the condition, highlighting areas for further research. The report also makes the case for increasing funding to deliver better outcomes for women with asthma, strengthening leadership and infrastructure in asthma treatment, and increasing innovation in drug trials. Alongside the report, Asthma and Lung UK has made a short video where one woman talks about her experience of severe asthma, how it has affected her life and why we need more research into the link between asthma, periods and female hormones. Asthma and Lung UK has also released a survey to find out more about women's experience of living with asthma.
- Posted
-
- Asthma
- Womens health
-
(and 3 more)
Tagged with:
-
News Article
Asthma research disadvantages women by disregarding sex hormones
Patient Safety Learning posted a news article in News
Women with asthma are twice as likely to die from an asthma attack compared with men in the UK, new figures show as health experts called for urgent research into the condition’s sex-related differences. They are more likely to have the condition, more likely to need hospital treatment for it and more likely to die from an attack, Asthma + Lung UK said. Over the past five years women have accounted for more than two-thirds of asthma deaths in the UK. The charity said the current “one size fits all” approach to asthma treatment is “not working” because it does not take into account the impact that female sex hormones during puberty, periods, pregnancy and menopause can have on asthma symptoms and attacks. More must be done to tackle the “stark health inequality”, it added. Between 2014-15 and 2019-20 more than 5,100 women in the UK died from an asthma attack compared with fewer than 2,300 men. Meanwhile, emergency hospital admissions in England show that, among those aged 20 to 49, women were 2.5 times more likely to be admitted to hospital for asthma treatment compared with men. Asthma + Lung UK said many people were unaware that fluctuations in female sex hormones can cause asthma symptoms to flare up or even trigger life-threatening attacks. It is calling for more research to examine the sex-related differences in asthma. Read full story Source: The Guardian, 27 April 2022- Posted
-
- Asthma
- Womens health
-
(and 3 more)
Tagged with:
-
News Article
Campaigners call for action over UK’s ‘shameful’ lung health
Patient Safety Learning posted a news article in News
The UK has the highest death rate for lung conditions in western Europe, research reveals, prompting calls from health leaders for urgent action to tackle the “national scandal”. More than 100,000 people in the UK die from conditions including asthma attacks, bronchitis, chronic obstructive pulmonary disease (COPD) and pneumonia every year, according to data analysis by the charity Asthma and Lung UK. Across Europe, only Turkey has a higher respiratory death rate than the UK, analysis of data up to 2018 shows. It described the UK figures as “shameful”, and said that lung conditions had for too long been treated like the “poor relation compared with other major illnesses like cancer and heart disease”. Even before the pandemic, significant numbers of lung patients were not receiving “basic care” from their GP services such as medicine checks and help using their inhalers, the charity said. Over the past two years, the health of thousands more has deteriorated while they waited for respiratory care, and diagnosis rates have fallen. Katy Brown, 64, a retired nursery nurse from Bristol, who was diagnosed with COPD in February 2021, said she was shocked by the lack of medical support she has received, and the poor general awareness of her condition. “I spent two years struggling to breathe and with constant chest infections, before I finally got a diagnosis of COPD,” she said. “Even now, over a year after my diagnosis, I’m still waiting for a test that will show how bad my condition is, and further treatment. “There is a lack of awareness about how serious lung conditions are and how terrifying it is to struggle to breathe. It’s like having an elephant sitting on your chest. If I’d been diagnosed with another serious condition like a heart problem, I believe my treatment and the way I was dealt with would have been completely different.” Read full story Source: The Guardian, 28 February 2022- Posted
-
- Medicine - Respiratory
- Asthma
- (and 1 more)
-
Content ArticleThis self-assessment tool has been developed by the British Lung Foundation for people with Long Covid symptoms. It aims to help patients identify and prioritise their needs, signposts them to further information and outlines the help they should get in dealing with Long Covid. It is anonymous and takes 5-10 minutes to complete. Patients can also print out their answers and share them with healthcare professionals an employers to clearly highlight an individual's needs.
- Posted
-
- Long Covid
- Asthma
- (and 5 more)
-
News Article
NHS drug pledge broken for asthma sufferers and smokers, report reveals
Patient Safety Learning posted a news article in News
A promise to ensure that people with severe asthma and smokers who want to quit can get the drugs they need has been broken by ministers and the NHS, a health service report reveals. Health charities criticised the persistent lack of access to vital medications for patients in England as very worrying and warned that it could damage the health of those affected. In 2019 the Department of Health and Social Care (DHSC), NHS England, Association of the British Pharmaceutical Industry (ABPI) and makers of branded medicines signed an agreement, called the voluntary scheme, to increase the number of patients able to obtain cost-effective medicines on the NHS. It covered five key areas of disease in which receipt of drugs would result in “high health gain”. These were cystic fibrosis, severe asthma, stopping smoking by using the drug varenicline, hepatitis C and atrial fibrillation and thromboembolism. However, a report which NHS England commissioned – but has not published – shows that while the target has been met for cystic fibrosis and hepatitis C, it has been missed for severe asthma and smokers seeking to quit using varenicline. It compares England’s progress against that in 10 other European countries, including France, Spain and Italy. “It’s deeply concerning that England languishes near the bottom of the league table for uptake of biologic treatments for severe asthma, the deadliest form of the condition,” said Alison Cook, the director of external affairs at Asthma UK and the British Lung Foundation. Read full story Source: The Guardian, 20 December 2021- Posted
-
- Asthma
- Substance / Drug abuse
- (and 3 more)
-
News Article
Poorly controlled asthma 'increases Covid risk for children'
Patient Safety Learning posted a news article in News
Children with poorly controlled asthma are up to six times more likely to be admitted to hospital with Covid than those without the condition, research has suggested. Scientists involved in the study said 5 to 17-year-olds in this category should be considered a priority for Covid vaccination. About 9,000 children in Scotland would benefit from the jab, researchers said. Vaccines are offered to the over-12s in Scotland, but not to younger children. In the study, poorly controlled asthma was defined as a prior hospital admission for the condition, or being prescribed at least two courses of oral steroids in the last two years. Prof Aziz Sheikh, director of the University of Edinburgh's Usher Institute and Eave II study lead, said: "Our national analysis has found that children with poorly controlled asthma are at much higher risk of Covid-19 hospitalisation. "Children with poorly controlled asthma should therefore be considered a priority for COVID-19 vaccination alongside other high-risk children." Prof Sheikh said it was important to consider both the "risks and benefits" from vaccinations. He added: "Emerging evidence from children aged five and older suggests that COVID-19 vaccines are overall well-tolerated by the vast majority of children." Read full story Source: BBC News, 1 December 2021 -
Content ArticleThe overarching objective of the national Adoption and Spread Safety Improvement Programme (A&S-SIP) is to identify and support the spread and adoption of effective and safe evidence-based interventions and practice. Each of the four objectives of this programme intend to make medical procedures, and discharges from acute settings, as safe as possible whilst driving forward innovation within healthcare. Learn how the programme is being delivered locally by the West of England Patient Safety Collaborative.
- Posted
-
- Innovation
- Quality improvement
- (and 4 more)
-
Content ArticleThe Healthcare Safety Investigation Branch (HSIB) held a webinar on 12 May to discuss asthma management in children, to support the launch of their recent publication: Management of chronic asthma in children aged 16 years and under. For those of you who missed the event, HSIB have made available the webinar recording, presentation slides and Q&As.
- Posted
-
- Asthma
- Investigation
- (and 2 more)
-
Content ArticleAsthma is the most common lung disease in the UK. 1.1 million children are diagnosed with the condition. Healthcare Safety Investigation Branch (HSIB) looked at the risks involved in the management of children aged 16 years and under diagnosed with asthma. Diagnosis and the management of asthma, particularly in children and young people, can be complex. It is important to get it right, as otherwise significant harm or death can result. The investigation was launched after HSIB identified an event involving a 5 year old child. The child had numerous planned and unplanned (emergency) attendances at hospital with respiratory symptoms, before suffering a near fatal asthma attack. Prior to the event, the child had no formal diagnosis of asthma and issues had been identified (but not resolved) regarding adherence to treatment.
- Posted
-
- Asthma
- Investigation
-
(and 1 more)
Tagged with: